Alzheimer’s disease and the basal forebrain cholinergic system: relations to β-amyloid peptides, cognition, and treatment strategies

This publication has 468 references indexed in Scilit:

• Donepezil
  Drugs & Aging, 2000
• Cholinesterase Inhibitors for the Treatment of Alzheimer??s Disease in the Elderly
  Drugs & Aging, 2000
• Cholinesterase Inhibitors in the Treatment of Alzheimer??s Disease
  Drug Safety, 1998
• Donepezil
  Drugs & Aging, 1997
• RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
  Nature, 1996
• Therapeutic potential of CNS-active M2 antagonists: Novel structures and pharmacology
  Life Sciences, 1993
• Memory and the hippocampus: A synthesis from findings with rats, monkeys, and humans.
  Psychological Review, 1992
• High-affinity uptake of choline, a marker for cholinergic nerve terminals, is not specific in developing rat brain
  Developmental Brain Research, 1987
• Physostigmine restores3H-acetylcholine efflux from Alzheimer brain slices to normal level
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1986
• Animal and Human Memory Dysfunctions Associated with Aging, Cholinergic Lesions, and Senile Dementia
  Annals of the New York Academy of Sciences, 1985